Limited data on females with mpox restricts understanding of potential sex-based disparities in treatment and outcomes. This study aims to investigate these differences using administrative claims and clinical data repositories.
Methods
We retrospectively analyzed adults diagnosed with mpox using TriNetX, stratifying cohorts by sex. The primary outcome included urgent care, emergency room, and hospitalization visits, with secondary outcomes including clinical findings, vaccination, and treatment.
Results
Among 2011 cases, 90% were male. Males were older, more likely to identify as Hispanic or Latino, and had higher HIV prevalence and sexually transmitted infection rates. Hospitalization rates were low for both groups, with similar healthcare utilization. However, males received fewer opioid analgesics, glucocorticoids, and antiemetics versus females. Vaccination and tecovirimat use were minimal in both groups.
Conclusion
Addressing sex disparities in mpox treatment and outcomes is crucial, but existing data sources like administrative claims and clinical data repositories pose limitations.
ThornhillJPBarkatiSWalmsleyS, et al.Monkeypox virus infection in humans across 16 countries - april-June 2022. N Engl J Med2022; 387: 679–691. DOI: 10.1056/NEJMoa2207323.
ThornhillJPPalichRGhosnJ, et al.Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series. Lancet2022; 400: 1953–1965. DOI: 10.1016/s0140-6736(22)02187-0.
4.
OakleyLPHufstetlerKO'SheaJ, et al.Mpox cases among cisgender women and pregnant persons - United States, may 11-November 7, 2022. MMWR Morb Mortal Wkly Rep2023; 72: 9–14. DOI: 10.15585/mmwr.mm7201a2.
5.
CoutinhoCSecco Torres SilvaMTorresTS, et al.Characteristics of women diagnosed with mpox infection compared to men: a case series from Brazil. Trav Med Infect Dis2023; 56: 102663. DOI: 10.1016/j.tmaid.2023.102663.
6.
Rodriguez-MoralesAJAmerFA. Monkeypox virus infection in women and non-binary people: uncommon or neglected?Lancet2022; 400: 1903–1905. DOI: 10.1016/s0140-6736(22)02396-0.
7.
PalchukMBLondonJWPerez-ReyD, et al.A global federated real-world data and analytics platform for research. JAMIA Open2023; 6: ooad035. DOI: 10.1093/jamiaopen/ooad035.
8.
TopalogluUPalchukMB. Using a federated network of real-world data to optimize clinical trials operations. JCO Clin Cancer Inform2018; 2: 1–10. DOI: 10.1200/cci.17.00067.
9.
BlosnichJRCashyJGordonAJ, et al.Using clinician text notes in electronic medical record data to validate transgender-related diagnosis codes. J Am Med Inf Assoc2018; 25: 905–908. DOI: 10.1093/jamia/ocy022.
10.
KerrPLBryantG. Use of ICD-10 codes for human trafficking: analysis of data from a large, multisite clinical database in the United States. Publ Health Rep2022; 137: 83S–90S.
11.
AustinPC. A comparison of 12 algorithms for matching on the propensity score. Stat Med2014; 33: 1057-1069. DOI: 10.1002/sim.6004.
12.
Suárez RodríguezBGuzmán HerradorBRDíaz FrancoA, et al.Epidemiologic features and Control measures during monkeypox outbreak, Spain, June 2022. Emerg Infect Dis2022; 28: 1847–1851. DOI: 10.3201/eid2809.221051.
13.
VaughanAMCenciarelliOColombeS, et al.A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022. Euro Surveill2022; 27: 2200620. DOI: 10.2807/1560-7917.Es.2022.27.36.2200620.
14.
CurranKGEberlyKRussellOO, et al.HIV and sexually transmitted infections among persons with monkeypox - eight U.S. Jurisdictions, May 17-July 22, 2022. MMWR Morb Mortal Wkly Rep2022; 71: 1141–1147. DOI: 10.15585/mmwr.mm7136a1.
15.
O'LaughlinKTobolowskyFAElmorR, et al.Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational New drug protocol - United States, May-August 2022. MMWR Morb Mortal Wkly Rep2022; 71: 1190–1195. DOI: 10.15585/mmwr.mm7137e1.
16.
SilvaMSTCoutinhoCTorresTS, et al.Ambulatory and hospitalized patients with suspected and confirmed mpox: an observational cohort study from Brazil. Lancet Reg Health Am2023; 17: 100406. DOI: 10.1016/j.lana.2022.100406.
17.
ContagCARenfroZTLuJ, et al.Prevalence of Mpox (Monkeypox) in patients undergoing STI screening in northern California, April-September 2022. J Clin Virol2023; 164: 105493. DOI: 10.1016/j.jcv.2023.105493.
SunCFXieHMetsutnanV, et al.The mean age of gender dysphoria diagnosis is decreasing. Gen Psychiatr2023; 36: e100972. DOI: 10.1136/gpsych-2022-100972.
22.
Perez DuqueMRibeiroSMartinsJV, et al.Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022. Euro Surveill : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022; 27220042. DOI: 10.2807/1560-7917.Es.2022.27.22.2200424.
23.
PhilpottDHughesCMAlroyKA, et al.Epidemiologic and clinical characteristics of monkeypox cases - United States, May 17-July 22, 2022. MMWR Morb Mortal Wkly Rep2022; 71: 1018–1022. DOI: 10.15585/mmwr.mm7132e3.
24.
PatelABilinskaJTamJCH, et al.Clinical features and novel presentations of human monkeypox in a central London Centre during the 2022 outbreak: descriptive case series. Bmj2022; 378: e072410. DOI: 10.1136/bmj-2022-072410.
25.
O'SheaJFilardoTDMorrisSB, et al.Interim guidance for prevention and treatment of monkeypox in persons with HIV infection - United States, August 2022. MMWR Morb Mortal Wkly Rep2022; 71: 1023–1028. DOI: 10.15585/mmwr.mm7132e4.
26.
AngeloKMSmithTCamprubí-FerrerD, et al.Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect Dis2022; 23: 196–206. DOI: 10.1016/S1473-3099(22)00651-X.
27.
ChastainDBMotoaGOrtiz-MartínezY, et al.Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort. Aids2023; 37: 611–616. DOI: 10.1097/qad.0000000000003449.
28.
MouradAAlavianNWoodhouseEW, et al.Concurrent sexually transmitted infection testing among patients tested for mpox at a tertiary healthcare system. Open Forum Infect Dis2023; 10: ofad381. DOI: 10.1093/ofid/ofad381.
29.
CiccareseGDi BiagioABruzzoneB, et al.Monkeypox outbreak in Genoa, Italy: clinical, laboratory, histopathologic features, management, and outcome of the infected patients. J Med Virol2023; 95: e28560. DOI: 10.1002/jmv.28560.
30.
MaukKCTorroneEAFlaggEW. Can diagnostic codes in health care claims data identify confirmed chlamydial and gonococcal infections? A retrospective cohort study, 2003 to 2017. Sex Transm Dis2021; 48: S26–s31. DOI: 10.1097/olq.0000000000001454.
31.
LiPLiJAyadaI, et al.Clinical features, antiviral treatment, and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks. J Infect Dis2023; 228: 391–401. DOI: 10.1093/infdis/jiad034.
32.
Henao-MartínezAFOrkinCMTitanjiBK, et al.Hospitalization risk among patients with mpox infection-a propensity score matched analysis. Ther Adv Infect Dis2023; 10: 20499361231196683. DOI: 10.1177/20499361231196683.
33.
MitjàOOgoinaDTitanjiBK, et al.Monkeypox. Lancet2023; 401: 60–74. DOI: 10.1016/s0140-6736(22)02075-x.
34.
TopalogluUPalchukMB. Using a federated network of real-world data to optimize clinical trials operations. JCO Clin Cancer Inform2018; 2: 1–10. DOI: 10.1200/cci.17.00067.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
